Asia Pacific Topical Scar Treatment Market Size & Outlook
Asia Pacific topical scar treatment market, 2018-2030 (US$M)
Related Markets
Asia Pacific topical scar treatment market highlights
- The Asia Pacific topical scar treatment market generated a revenue of USD 755.9 million in 2024.
- The market is expected to grow at a CAGR of 12.5% from 2025 to 2030.
- In terms of segment, creams was the largest revenue generating product in 2024.
- Silicon Sheets is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 755.9 million |
| Market revenue in 2030 | USD 1,528.1 million |
| Growth rate | 12.5% (CAGR from 2025 to 2030) |
| Largest segment | Creams |
| Fastest growing segment | Silicon Sheets |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Creams, Gels, Silicon Sheets |
| Key market players worldwide | Smith & Nephew PLC, Lumenis, Merz Pharma, Sonoma Pharmaceuticals Inc, Cynosure, CCA Industries Inc, Newmedical, Molnlycke Health Care, Suneva Medical, Pacific World Corporation, Perrigo Co PLC, Enaltus, SCAR |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 44.7% of the global topical scar treatment market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,528.1 million by 2030.
Creams was the largest segment with a revenue share of 40.22% in 2024. Horizon Databook has segmented the Asia Pacific topical scar treatment market based on creams, gels, silicon sheets covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia-Pacific topical scar treatment market is witnessing robust growth, driven by rising demand for innovative and effective scar management solutions. Increasing awareness of scar treatments, coupled with advancements in dermatology and wound care, is propelling market expansion.
Key players in the region are actively investing in R&D to develop advanced formulations like silicone-based products, creams, and gels that provide improved efficacy and patient comfort. Collaborations between pharmaceutical companies, research institutions, and healthcare providers are accelerating innovation and accessibility in scar treatment.
For instance, in April 2024, AFT Pharmaceuticals announced its collaboration with Massey Ventures, the commercial arm of Massey University, and the Gillies McIndoe Research Institute, a charitable research foundation in New Zealand, to initiate the development of a topical treatment targeting keloid and hypertrophic scarring.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Topical scar treatment market Scope
Topical scar treatment market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific topical scar treatment market report size, by country, 2018-2030 (US$M)
Asia Pacific Topical scar treatment market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
